Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test may forecast heart failure risk after heart attack

NCT ID NCT06885619

Recruiting now Knowledge-focused Sponsor: Beijing Anzhen Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is looking for clues in the blood that could predict if a person's heart will change shape or develop serious problems after a major heart attack. Researchers will collect blood samples and perform heart ultrasounds on 1,000 patients over six months. The goal is to find markers that could one day help doctors personalize care and prevent complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could lead to a blood test that helps doctors predict which heart attack patients are at higher risk for heart failure or other complications.
What could go wrong
This is an observational study, not a treatment trial. It may not find reliable markers, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ST-elevation myocardial infarction Ventricular Remodeling

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION IMMUNOMICS LEFT VENTRICULAR REMODELING MAJOR ADVERSE CARDIOVASCULAR EVENTS PLASMA MULTI-OMICS

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Beijing Anzhen Hospital, Capital Medical University.

    RECRUITING

    Beijing, Beijing Municipality, 100029, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.